Literature DB >> 6662655

Study of the relationships between pericarditis and osteopathy in chronic haemodialysis.

J Makó, J Szücs, G Gaizler, M Lengyel, J Mérei.   

Abstract

Statistically significant correlations were demonstrable between the incidence of bone abnormalities due to parathyroid hyperfunction and of pericarditis in 130 patients maintained on chronic haemodialysis. Parathyroid hormone is regarded on these grounds as one of the possible factors accounting for the production of non-infective uraemic pericarditis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662655     DOI: 10.1007/bf02082559

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  6 in total

1.  [Correlation of serum parathyroid hormone level with other parameters of secondary hyperparathyroidism in renal insufficiency].

Authors:  H Loew; M Hrubesch; R Meermann
Journal:  Med Welt       Date:  1976-11-19

2.  Clinical evaluation of bone-densitometry in patients with final renal insufficiency operated for hyperparathyroidism.

Authors:  B Lindergård; P Gullstrand; S Rydmarker; S Tibblin
Journal:  Scand J Urol Nephrol       Date:  1977

Review 3.  Pericarditis in renal disease.

Authors:  S Kumar; M Lesch
Journal:  Prog Cardiovasc Dis       Date:  1980 Mar-Apr       Impact factor: 8.194

4.  [Diagnostic and therapeutic questions about pericarditis in patients under chronic hemodialysis].

Authors:  J Mako; M Lengyel; S Békassy; G Gaizler; M Kökény; L Nagy; A Hamvas; B Balogh
Journal:  Orv Hetil       Date:  1981-02-22       Impact factor: 0.540

5.  Pericarditis in the patient with uremia: clinical and echocardiographic evaluation.

Authors:  F C Luft; J K Gilman; A E Weyman
Journal:  Nephron       Date:  1980       Impact factor: 2.847

6.  Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility.

Authors:  R S Goldsmith; J Furszyfer; W J Johnson; A E Fournier; G W Sizemore; C D Arnaud
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.